Cotrimoxazol plus rifampicin in the treatment of staphylococcic osteoarticular infection;Cotrimoxazol mas rifampicina en el tratamiento de la infeccion osteoarticular estafilococica

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 15, Issue 1, 1997, Pages 10-13

  Sánchez, Carlos ^a,b   Matamala, Alfredo ^b   Salavert, Miguel ^a   Cuchí, Eva ^a   Pons, Miguel ^b   Anglés, Francesc ^b   Garau, Javier ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL MÚTUA DE TERRASSA   (Spain)

Author keywords

cotrimoxazol; orthopedic prostheses; osteomyelitis; rifampicin; Staphylococcus

Indexed keywords

COTRIMOXAZOLE; RIFAMPICIN; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE INFECTION; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; LIVER TOXICITY; MALE; NAUSEA; OSTEOARTHROPATHY; OSTEOMYELITIS; RASH; SCHOOL CHILD; BACTEREMIA; CHILD; DRUG COMBINATION; LUMBAR VERTEBRA; MIDDLE AGED; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; SPONDYLITIS; STAPHYLOCOCCUS INFECTION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; CHILD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOMYELITIS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RIFAMPIN; SPONDYLITIS; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0030638873     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Norden CW, Bryant R, Palmer D, Montgomerie JZ, Wheat J and the Chronic Staphylococcal Osteomyelitis Study Group. Chronic Osteomyelitis caused by Staphylococcus aureus: controlled clinical trial of nafcillin theraphy and nafcillin-rifampin therapy. South Med J 1986; 79: 947-951.
2. Sabath LD, Garner C, Wilcox C, Finland M. Susceptibility of Staphylococcus aureus and Staphylococcus epidermis to 65 antibiotics. Antimicrob Agents Chemother 1976; 9: 962-969.
3. Norden CW, Keleti E. Treatment of experimental staphylococcal osteomyelitis with rifampin and trimethoprim, alone and in combination. Antimicrob Agents Chemother 1980; 17: 591-594.
4. Cluzel RA, Lopitaux R, Sirot J, Rampon S. Rifampicin in the treatment of osteoarticular infections due to staphylococci. J Antimicrob Chemother 1984; 13 Supl C: 23-29.
5. Widmer AF, Frei R, Rajacic Z, Zimmerli W. Correlation between in vivo and in vitro efficacy of antimicrobial agents against forcing body infections. J Infect Dis 1990; 162: 96-102.
6. Norden CW, Fierer J, Bryant RE and the Chronic Staphylococcal Osteomyelitis Study Group. Chronic Staphylococcal osteomyelitis: treatment with containing rifampin. Rev Infect Dis 1983; 5: S495-S501.
7. Widmer AF, Gaetchter A, Ochsner PE, Zimmerli W. Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations. Clin Infect Dis 1992; 14: 1.251-1.253.
8. Clumeck N, Marcelis L, Amiri-Lamraski MH, Gordts B. Treatment of severe staphylococcal infections with a rifampicin-minocycline association. J Antimicrob Chemother 1984; 13 Supl C: 17-22.
9. Drancourt M, Stein A, Argenson, Zannier A, Curvale G, Raoult D. Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants. Antimicrob Agents Chemother 1993; 37: 1.214-1.218.
10. Kissling M, Bergamini N. Rifampicin in free combination with other antimicrobial drugs in non-tb infections. Chemotherapy 1981; 27: 368-402.
11. Craven JL, Pugsley DJ, Blowers R. Trimethoprim-sulphamethoxazole in acute osteomyelitis due to penicillin-resistant staphylococci in Uganda. Br Med J 1970; 3: 201-203.
12. Trimethoprim-sulfamethoxazole: report of clinical trials in Japan. J Infect Dis 1973; 128: S629-635.
13. Saengnipanthkul S, Pongvivat T, Mahaisavariya B, Laupattarakasem W. Co-trimoxazole in the treatment of chronic osteomyelitis. J Med Assoc Thai 1988; 71: 186-191.
14. Yeldandi V, Strodman R, Lentino JR. In-vitro and in-vivo studies of trimethoprim-sulphamethoxazole against multiple resistant Staphylococcus aureus. J Antimicrob Chemother 1988; 22: 873-880.
15. Bouza E, Parras F, Mun̄oz P et al. Eficacia del cotrimoxazol en el tratamiento de infecciones estafilocócicas graves. [resumen 217]. Enferm Infecc Microbiol Clin 1992; 10: Supl 2: 86.
16. Reller LB, Stratton CW. Serum dilution test for bactericidal activity. II. Standardization and correlation with antimicrobial assays and susceptibility tests. J Infect Dis 1977; 136: 196-203.
17. Jacobs RF, Wilson CB. Intracellular penetration and antimicrobial activity of antibiotics. J Antimicrob Chemother 1983; 12 Supl C: 13-20.
18. Suter F, Maserati R, Concia E et al. Rifampicin in collections of pus - a kinetic study in human abscesses. J Antimicrob Chemother 1984; 13 Supl C: 43-47.
19. Norden CW. Experimental osteomyelitis. IV. Therapeutic trials with rifampin alone and in combination with gentamicin, sisomicin, and cephalotin. J Infect Dis 1975; 132: 493-499.
20. Alvarez S, DeMaria A, Kulkarni R, Klein JO, McCabe WR. Interactions of rifampin and trimethoprim in vitro. Rev Infect Dis 1982; 4: 390-401.
21. Kerry DW, Hamilton-Miller JMT, Brumfitt. Trimethoprim and rifampicin: in vitro activities separately and in combination. J Antimicrob Chemother 1975; 1: 417-427.
22. Hackbarth CJ, Chambers HF, Sande MA. Serum bactericidal activity rifampin in combination with other antimicrobial agents against Staphylococcus aureus. Antimicrob Agents Chemother 1986; 29: 611-613.
23. Mandell GL, Moorman DR. Treatment of experimental staphylococcal infections: effect of rifampin alone and in combination on development of rifampin resistance. Antimicrob Agents Chemother 1980; 17: 658-662.
24. Norden CW. Lessons learned from animal models of osteomyelitis. Rev Infect Dis 1988; 10: 103-110.
25. Grüneberg RN, Emmerson AM, Ridgway GL. Rifampicin-containing antibiotic combinations in the treatment of difficult infections. J Antimicrob Chemother 1984; 13 Supl C: 49-55.
26. Nitsche A, Mogni GO, Gorostiaga PE. Septic arthritis of the pubic symphysis. Clin Experim Rheumatol 1989; 7: 421-422.